176 related articles for article (PubMed ID: 30286050)
1. Rs4938723 Polymorphism Is Associated with Susceptibility to Hepatocellular Carcinoma Risk and Is a Protective Factor in Leukemia, Colorectal, and Esophageal Cancer.
Xu B; Zhu Y; Tang Y; Zhang Z; Wen Q
Med Sci Monit; 2018 Oct; 24():7057-7071. PubMed ID: 30286050
[TBL] [Abstract][Full Text] [Related]
2. Association between miR-34b/c rs4938723 polymorphism and risk of cancer: An updated meta-analysis of 27 case-control studies.
Hashemi M; Moazeni-Roodi A; Bahari G; Taheri M; Ghavami S
J Cell Biochem; 2019 Mar; 120(3):3306-3314. PubMed ID: 30203457
[TBL] [Abstract][Full Text] [Related]
3. Lack of association of MiR-34b/c polymorphism (rs4938723) with hepatocellular carcinoma: a meta-analysis.
Liang TJ; Liu HJ; Zhao XQ; Yu CH; Li CS
PLoS One; 2013; 8(7):e68588. PubMed ID: 23935875
[TBL] [Abstract][Full Text] [Related]
4. The genetic association between pri-miR-34b/c polymorphism (rs4938723 T > C) and susceptibility to cancers: evidence from published studies.
Li X; Wang L; Yu J; Xu J; Du J
Tumour Biol; 2014 Dec; 35(12):12525-34. PubMed ID: 25190019
[TBL] [Abstract][Full Text] [Related]
5. An updated meta-analysis of 23 case-control studies on the association between miR-34b/c polymorphism and cancer risk.
Li H; Diao S; Li J; Ma B; Yuan S
Oncotarget; 2017 Apr; 8(17):28888-28896. PubMed ID: 28415817
[TBL] [Abstract][Full Text] [Related]
6. A potentially functional polymorphism in the promoter region of miR-34b/c is associated with an increased risk for primary hepatocellular carcinoma.
Xu Y; Liu L; Liu J; Zhang Y; Zhu J; Chen J; Liu S; Liu Z; Shi H; Shen H; Hu Z
Int J Cancer; 2011 Jan; 128(2):412-7. PubMed ID: 20309940
[TBL] [Abstract][Full Text] [Related]
7. Associations of pri-miR-34b/c and pre-miR-196a2 polymorphisms and their multiplicative interactions with hepatitis B virus mutations with hepatocellular carcinoma risk.
Han Y; Pu R; Han X; Zhao J; Zhang Y; Zhang Q; Yin J; Xie J; Shen Q; Deng Y; Ding Y; Li W; Li J; Zhang H; Cao G
PLoS One; 2013; 8(3):e58564. PubMed ID: 23516510
[TBL] [Abstract][Full Text] [Related]
8. Association between polymorphisms in the promoter region of pri-miR-34b/c and risk of hepatocellular carcinoma.
Chen LL; Shen Y; Zhang JB; Wang S; Jiang T; Zheng MQ; Zheng ZJ; Chen CX
Genet Mol Res; 2016 Oct; 15(4):. PubMed ID: 27808368
[TBL] [Abstract][Full Text] [Related]
9. Hsa-miR-34b/c rs4938723 T>C and hsa-miR-423 rs6505162 C>A polymorphisms are associated with the risk of esophageal cancer in a Chinese population.
Yin J; Wang X; Zheng L; Shi Y; Wang L; Shao A; Tang W; Ding G; Liu C; Liu R; Chen S; Gu H
PLoS One; 2013; 8(11):e80570. PubMed ID: 24260422
[TBL] [Abstract][Full Text] [Related]
10. Pri-miR-124 rs531564 and pri-miR-34b/c rs4938723 polymorphisms are associated with decreased risk of esophageal squamous cell carcinoma in Chinese populations.
Zhang J; Huang X; Xiao J; Yang Y; Zhou Y; Wang X; Liu Q; Yang J; Wang M; Qiu L; Zheng Y; Zhang P; Li J; Wang Y; Wei Q; Jin L; Wang J; Wang M
PLoS One; 2014; 9(6):e100055. PubMed ID: 24945256
[TBL] [Abstract][Full Text] [Related]
11. Association of TP53 rs1042522 C>G and miR-34b/c rs4938723 T>C polymorphisms with hepatoblastoma susceptibility: A seven-center case-control study.
Liu P; Zhuo ZJ; Zhu J; Yang Z; Xin Y; Li S; Li L; Li Y; Wang H; He J
J Gene Med; 2020 Jul; 22(7):e3182. PubMed ID: 32166848
[TBL] [Abstract][Full Text] [Related]
12. Pri-miR-34b/c rs4938723 Polymorphism Contributes to Coronary Artery Disease Susceptibility.
Cen J; Xiong Q; Yang X; Guo J; Xiong XD; Zhang A
Arch Med Res; 2019 May; 50(4):170-174. PubMed ID: 31499476
[TBL] [Abstract][Full Text] [Related]
13. Pri-miR-34b/c rs4938723 TC heterozygote is associated with increased cancer risks: evidence from published data.
Yi DH; Wang BG; Zhong XP; Liu H; Liu YF
Tumour Biol; 2014 Dec; 35(12):11967-75. PubMed ID: 25201061
[TBL] [Abstract][Full Text] [Related]
14. Significant association among the Fas -670 A/G (rs1800682) polymorphism and esophageal cancer, hepatocellular carcinoma, and prostate cancer susceptibility: a meta-analysis.
Liu T; Zuo L; Li L; Yin L; Liang K; Yu H; Ren H; Zhou W; Jing H; Liu Y; Kong C
Tumour Biol; 2014 Nov; 35(11):10911-8. PubMed ID: 25085585
[TBL] [Abstract][Full Text] [Related]
15. rs3746444 polymorphism and susceptibility to hepatocellular carcinoma: evidence from published studies.
Liu F; Lin H; Cheng Y; Yang L; Liu Y
Cell Biochem Biophys; 2014 Dec; 70(3):1957-61. PubMed ID: 25074528
[TBL] [Abstract][Full Text] [Related]
16. Association between hsa-miR-34b/c rs4938723 T > C promoter polymorphism and cancer risk: a meta-analysis based on 6,036 cases and 6,204 controls.
Tao T; Chen S; Xu B; Liu C; Wang Y; Huang Y; Chen M
Chin J Cancer Res; 2014 Jun; 26(3):315-22. PubMed ID: 25035659
[TBL] [Abstract][Full Text] [Related]
17. Pri-miR-34b/c rs4938723 polymorphism contributes to acute lymphoblastic leukemia susceptibility in Chinese children.
Tong N; Chu H; Wang M; Xue Y; Du M; Lu L; Zhang H; Wang F; Fang Y; Li J; Wu D; Zhang Z; Sheng X
Leuk Lymphoma; 2016; 57(6):1436-41. PubMed ID: 26380954
[TBL] [Abstract][Full Text] [Related]
18. MiR-34b/c rs4938723 Polymorphism Significantly Decreases the Risk of Digestive Tract Cancer: Meta-analysis.
Ji TX; Zhi C; Guo XG; Zhou Q; Wang GQ; Chen B; Ma FF
Asian Pac J Cancer Prev; 2015; 16(14):6099-104. PubMed ID: 26320502
[TBL] [Abstract][Full Text] [Related]
19. Pri-miR-34b/c rs4938723 polymorphism increased the risk of prostate cancer.
Hashemi M; Danesh H; Bizhani F; Narouie B; Sotoudeh M; Nouralizadeh A; Sharifiaghdas F; Bahari G; Taheri M
Cancer Biomark; 2017; 18(2):155-159. PubMed ID: 27983526
[TBL] [Abstract][Full Text] [Related]
20. Combined analysis of pri-miR-34b/c rs4938723 and TP53 Arg72Pro with cervical cancer risk.
Yuan F; Sun R; Chen P; Liang Y; Ni S; Quan Y; Huang J; Zhang L; Gao L
Tumour Biol; 2016 May; 37(5):6267-73. PubMed ID: 26619844
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]